Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

- 40.6

__________ __________

Profit for the year 82.4 56.2

__________ __________

5

Earnings per share (expressed in cents per

share)

- Basic 15.3c 11.2c

- Diluted 15.0c 11.0c

__________ __________

Earnings per share from continuing 5

operations (expressed in cents per share)

- Basic 15.3c 3.1c

- Diluted 15.0c 3.0c

__________ __________

The accompanying notes are an integral part of these consolidated financial statements.

The profit for the year is all attributable to the equity holders of the parent.

Consolidated statement of recognised income and expense

2007 2006

Year to December 31, Notes US$M US$M

________ __________ __________

Profit for the year 82.4 56.2

__________ __________

Exchange differences on translation of

foreign operations 24.2 26.7

Unrealised holding loss on

available-for-sale securities, net of taxes

of US$5.2 million (2006: US$nil) (16.5) (1.8)

Realised gain on available-for-sale

securities
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Capital Edge Consulting , a nationwide ... pleased to announce their ranking as one of the top 5000 companies listed on ... companies across the nation. , “It is truly an honor to be recognized as ...
(Date:8/27/2015)... 27, 2015 The National Necrotizing Fasciitis ... life—were saved by doctors at Vanderbilt University Hospital in ... NovaBay Pharmaceuticals and Dr. John Crew , director ... Seton Medical Center in Daly City, CA. ... breakthrough approach, pioneered by Dr. Crew, that had previously ...
(Date:8/27/2015)... , Aug. 27, 2015 HUYA Bioscience International ... of the Japan Society of HTLV-1, held this week ... The purpose of the Society is to promote research ... development of medical technology and research related to these ... "HUYA is proud to support this prestigious ...
(Date:8/27/2015)... ... 27, 2015 , ... METTLER TOLEDO's web-based EasyFinder™ ... choices to a manageable shortlist of bench and floor scales and terminals. Specifying ... best with the customer’s industry and application. , Side-by-side product comparisons and ...
Breaking Biology Technology:Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4METTLER TOLEDO Updates Online Scale Selection Tool 2
... EATONTOWN, N.J., Dec. 11 Osteotech, Inc.,(Nasdaq: ... biologic products for,regenerative healing, announced today that its Board ... up to $5.0 million of,Osteotech,s common stock may be ... time at current market prices through open-market and privately,negotiated ...
... Netherlands, Dec. 11 Myngle,( http://www.myngle.com ), the ... winning ICT company at the Europe Unlimited,s European ... EVS is a showcase ... biotech and new energy entrepreneurs from all over ...
... Neogen Corporation,(Nasdaq: NEOG ) announced today that ... to purchase up to 500,000 shares of the company,s,common stock. ... program first approved in 1999. , ... market or in negotiated,transactions, depending on market conditions and other ...
Cached Biology Technology:Osteotech Announces Stock Repurchase Program 2Myngle Best ICT Company at the European Ventures Summit 2Neogen Announces New Share Repurchase Program 2
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/18/2015)... , Aug. 17, 2015 Research and ... of the "Global Biometric Authentication & Identification ... Estimation & Forecast, 2015-2020" report to their ... and identification systems market is expected to grow ... to 2020 and generate over $25 billion (approximately) ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions , ... entire spectrum of clinical research, is proud to announce ... company,s comprehensive SaaS-based eClinical technology platform, has led the ... first two quarters of 2015.   Q2 2015 and ... quarters measured by contract value sold in the company,s ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
... to stitch graphene and hexagonal boron nitride (h-BN) into ... for materials scientists. The technique has implications for ... below the limitations of silicon determined by Moore,s Law. ... Rice,s Benjamin M. and Mary Greenwood Anderson Professor in ...
... March 1, 2010 The underlying causes of the debilitating ... study published online in Genome Research March ... network analysis has revealed surprising new insights into how ... Researchers are actively working to identify the direct ...
... ... ... ... ...
Cached Biology News:Rice researchers make graphene hybrid 2Rice researchers make graphene hybrid 3Scientists identify age-associated defects in schizophrenia 2Oberthur Technologies Receives Product Innovation Award 2Oberthur Technologies Receives Product Innovation Award 3Oberthur Technologies Receives Product Innovation Award 4Oberthur Technologies Receives Product Innovation Award 5